Selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor use and sexual dysfunction: a pharmacovigilance analysis. [PDF]
Shen M +6 more
europepmc +1 more source
Sertraline safety in adolescents experiencing a depressive episode during first 3 weeks: added anxiolytic matters more than CYP2C19 polymorphisms. [PDF]
Ivashchenko DV +12 more
europepmc +1 more source
Real-World Assessment of Transcranial Direct Current Stimulation (tDCS) Combined with Sertraline in the Treatment of Depression in Vietnam. [PDF]
Do TX +11 more
europepmc +1 more source
Behavioural and transcriptional changes in the amphipod Echinogammarus marinus exposed to two antidepressants, fluoxetine and sertraline [PDF]
Bossus, Maryline C. +4 more
core +1 more source
Case Report: Pharmacogenetically-triggered fatal serotonin syndrome following sequential serotonergic therapy in Parkinson's disease: a case highlighting the role of <i>CYP2D6*10/*10</i> genotype and multifactorial drug interactions. [PDF]
Liu DY, Yi YH, Li N, Luo FM, Gong WJ.
europepmc +1 more source
Comparative effect of vortioxetine and sertraline on clinical and inflammatory profile in Parkinson's disease with comorbid depression. [PDF]
Alborghetti M +13 more
europepmc +1 more source
Sertraline for the Treatment of Major Depressive Disorder in the US: Effectiveness and Acceptability in Real-World Practice. [PDF]
Correll CU +7 more
europepmc +1 more source
Sertraline can alleviate neuronal and synaptic damage in the hippocampus of PTSD mice and inhibit the increase in myelin. [PDF]
Lu J +5 more
europepmc +1 more source
Exploring the Effect of Genetic Testing on Personalised Treatment Plans for Depression. [PDF]
Li S, Peng L, Wang Y.
europepmc +1 more source
Early intervention in anxiety disorder patients with clinical high-risk factors for bipolar disorder: A randomized controlled trial. [PDF]
Wang H +5 more
europepmc +1 more source

